trending Market Intelligence /marketintelligence/en/news-insights/trending/RMtWRTgrOEkEpEG9MizL4Q2 content esgSubNav
In This List

Premier Biomedical to form JV to manufacture, sell anti-addiction patches

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Premier Biomedical to form JV to manufacture, sell anti-addiction patches

Premier Biomedical Inc. agreed to form a joint venture with New Earth Development Corp., RushNet Inc., and XYZ Hemp Inc. to manufacture and sell anti-addiction patches.

The product will be based on topical pain relieving patch technology marketed by Premier Biomedical.

The anti-addiction patch contains hemp oil extracts and a patented combination of U.S. Food and Drug Administration-approved drugs naltrexone and cyclobenzaprine.

The patch is expected to eliminate a desire for opioid abuse. Each patch is designed to provide continuous treatment for seven to 10 days.

The joint venture is targeting global sales due to the opioid epidemic in the U.S. and internationally, Premier Biomedical said in a news release.